New growth formula
The US market remains choppy but Natco Pharma is becoming a compelling bet by rebooting itself with a new strategy
Prathamesh Mulye - November 04, 2019
Frontier Troops
Young medtech companies are working on oncology solutions, braving turbulent market conditions
Shilpa Elizabeth Abraham - January 07, 2019
Cherry-Picking Fallen Angels — Part 2
Here is a list of stocks that have fallen in the small and mid-cap carnage despite reporting robust numbers
Prathamesh Mulye - July 19, 2018
Right Antidote
Laurus Lab founder Satyanarayana Chava increases stake as the stock loses steam post its weak show in Q4FY18
Anushka Gupta - July 10, 2018
Inflection point
Laurus Labs is crucially poised, as investors look forward to its R&D efforts finally paying off
Khushboo Balani - April 04, 2018
Bold and Bountiful
Not content with the initial win in biosimiliars, Kiran Mazumdar-Shaw is pushing new frontiers in biologics
Kripa Mahalingam - July 11, 2017
Master Innovator
Vishnukant Bhutada’s big bet on oncology has catapulted Shilpa Medicare into the global generics space
Shilpa Elizabeth Abraham - June 09, 2017
Niraj Dalal
Sun Pharma has a robust pipeline in specialty business which will drive its profitability and free cash flow in the near future
January 13, 2017
Daljeet Singh Kohli
The time has come for Shilpa Medicare to reap the benefits of the hard work done by its management over the past few years
January 13, 2017
Manish Bhandari
Vallum Capital Advisors' Manish Bhandari foresees a bright future for oncology specialist Shilpa Medicare
May 11, 2015
